In October 2023, MeDomino was successfully recognized as a Beijing "Innovative" SME. The leading product that supported this recognition, MeDomino Content Hub, was also recently approved by the China National Intellectual Property Administration as a registered trademark. This means the name "MeDomino Content Hub" is now exclusively ours.
Since it has received national recognition, it is worth introducing again in full:
MeDomino Content Hub was created specifically for content management in the pharma and medtech industry. It belongs to the key software field within the "six industrial foundations." It solves long-standing pain points that have troubled pharma and medtech companies, including large content volumes, dispersed storage, messy content formats, difficulty in centralized management, difficulty forming enterprise-level knowledge bases, and difficulty with precise reuse. It fills a gap in the digital marketing field for the pharma and medtech industry.
In the future, MeDomino will continue insisting on technological innovation and keep improving product capabilities, helping the pharma and medtech industry effectively reduce marketing costs, improve operating efficiency, develop legally and compliantly, and contribute to the smooth advancement of Healthy China 2030.
